Novozymes As Stock Five Year Return
NVZMY Stock | USD 59.52 3.73 6.69% |
Novozymes AS fundamentals help investors to digest information that contributes to Novozymes' financial success or failures. It also enables traders to predict the movement of Novozymes Pink Sheet. The fundamental analysis module provides a way to measure Novozymes' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novozymes pink sheet.
Novozymes |
Novozymes AS Company Five Year Return Analysis
Novozymes' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Novozymes Five Year Return | 1.38 % |
Most of Novozymes' fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novozymes AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Novozymes AS has a Five Year Return of 1.38%. This is much higher than that of the Basic Materials sector and significantly higher than that of the Specialty Chemicals industry. The five year return for all United States stocks is notably lower than that of the firm.
Novozymes Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novozymes' direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Novozymes could also be used in its relative valuation, which is a method of valuing Novozymes by comparing valuation metrics of similar companies.Novozymes is currently under evaluation in five year return category among related companies.
Novozymes Fundamentals
Return On Equity | 0.28 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.21 % | |||
Operating Margin | 0.26 % | |||
Current Valuation | 14.47 B | |||
Shares Outstanding | 276.6 M | |||
Price To Earning | 34.25 X | |||
Price To Book | 6.12 X | |||
Price To Sales | 0.80 X | |||
Revenue | 17.55 B | |||
Gross Profit | 9.59 B | |||
EBITDA | 6.11 B | |||
Net Income | 3.69 B | |||
Cash And Equivalents | 1.01 B | |||
Cash Per Share | 3.67 X | |||
Total Debt | 7.31 B | |||
Debt To Equity | 0.58 % | |||
Current Ratio | 1.20 X | |||
Book Value Per Share | 50.02 X | |||
Cash Flow From Operations | 4.01 B | |||
Earnings Per Share | 1.90 X | |||
Price To Earnings To Growth | 3.81 X | |||
Target Price | 51.26 | |||
Number Of Employees | 6.44 K | |||
Beta | 0.4 | |||
Market Capitalization | 14.41 B | |||
Total Asset | 27.98 B | |||
Retained Earnings | 9.99 B | |||
Working Capital | 2.67 B | |||
Current Asset | 6.08 B | |||
Current Liabilities | 3.41 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Five Year Return | 1.38 % | |||
Net Asset | 27.98 B | |||
Last Dividend Paid | 6.0 |
About Novozymes Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novozymes AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novozymes using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novozymes AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novozymes in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novozymes' short interest history, or implied volatility extrapolated from Novozymes options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novozymes AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Novozymes Pink Sheet analysis
When running Novozymes' price analysis, check to measure Novozymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes is operating at the current time. Most of Novozymes' value examination focuses on studying past and present price action to predict the probability of Novozymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes' price. Additionally, you may evaluate how the addition of Novozymes to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |